title: The FDA and prescription pancreatic enzyme product cost.
authors.affiliation: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
authors.forename: Timothy B
authors.initials: TB
authors.lastname: Gardner
authors.affiliation: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Munson
authors.affiliation: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Morden
mesh_terms: D000681:Amylases / Q000191:economics*; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D006297:Health Services Accessibility / Q000191:economics; D008049:Lipase / Q000191:economics*; D010447:Peptide Hydrolases / Q000191:economics*; D011306:Prescription Fees / Q000706:statistics & numerical data / Q000639:trends*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
chemical_list: D004338:Drug Combinations; D008049:Lipase; D000681:Amylases; D010447:Peptide Hydrolases